Analysis of re-infection cases and influencing factors post first severe COVID-19 wave in Jiangsu Province, China.

IF 1.4 4区 医学 Q4 INFECTIOUS DISEASES
Qigang Dai, Changjun Bao, Hao Ju, Na Li, Shizhi Wang, Jiaxin Wen, Qiang Zhou, Liling Chen, Yujun Chen, Lei Xu, Xin Zhou, Songning Ding, Jianli Hu, Fengcai Zhu
{"title":"Analysis of re-infection cases and influencing factors post first severe COVID-19 wave in Jiangsu Province, China.","authors":"Qigang Dai, Changjun Bao, Hao Ju, Na Li, Shizhi Wang, Jiaxin Wen, Qiang Zhou, Liling Chen, Yujun Chen, Lei Xu, Xin Zhou, Songning Ding, Jianli Hu, Fengcai Zhu","doi":"10.3855/jidc.20031","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to assess COVID-19 re-infection rates among individuals previously infected between 2020 and November 2022, particularly during the first wave of high-intensity transmission, and to identify the risk factors associated with re-infection in Jiangsu Province, China.</p><p><strong>Methodology: </strong>Epidemiological investigations were conducted through telephone interviews and face-to-face visits in February and March 2023. Statistical analyses included the Chi-square or Fisher`s exact test for categorical data, Student's t-test for numerical data, Poisson regression for influencing factors, and Kaplan-Meier for cumulative re-infection risk.</p><p><strong>Results: </strong>Among 12,910 individuals surveyed, 957 (7.4%) cases of re-infection were identified. Re-infection rates varied significantly by initial infection period: 42.5% in January-February 2020, 15.5% in July-August 2021, 6.7% in March-April 2022, and 1.1% in September-October 2022. Females and individuals aged 18-50 years were more susceptible to re-infection. A reduced risk of re-infection was observed in those who received four vaccine doses, with a relative risk of 0.25 (p = 0.019).</p><p><strong>Conclusions: </strong>For populations prone to COVID-19 re-infections, particularly females and young adults aged 18-50 years, receiving four or more vaccine doses effectively reduces the likelihood of repeated infections. These findings emphasize the need to prioritize vaccination and protect high-risk groups in COVID-19 prevention efforts.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"18 9.1","pages":"S92-S100"},"PeriodicalIF":1.4000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3855/jidc.20031","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: This study aimed to assess COVID-19 re-infection rates among individuals previously infected between 2020 and November 2022, particularly during the first wave of high-intensity transmission, and to identify the risk factors associated with re-infection in Jiangsu Province, China.

Methodology: Epidemiological investigations were conducted through telephone interviews and face-to-face visits in February and March 2023. Statistical analyses included the Chi-square or Fisher`s exact test for categorical data, Student's t-test for numerical data, Poisson regression for influencing factors, and Kaplan-Meier for cumulative re-infection risk.

Results: Among 12,910 individuals surveyed, 957 (7.4%) cases of re-infection were identified. Re-infection rates varied significantly by initial infection period: 42.5% in January-February 2020, 15.5% in July-August 2021, 6.7% in March-April 2022, and 1.1% in September-October 2022. Females and individuals aged 18-50 years were more susceptible to re-infection. A reduced risk of re-infection was observed in those who received four vaccine doses, with a relative risk of 0.25 (p = 0.019).

Conclusions: For populations prone to COVID-19 re-infections, particularly females and young adults aged 18-50 years, receiving four or more vaccine doses effectively reduces the likelihood of repeated infections. These findings emphasize the need to prioritize vaccination and protect high-risk groups in COVID-19 prevention efforts.

中国江苏省首次严重 COVID-19 后再感染病例及影响因素分析。
导言:本研究旨在评估2020年至2022年11月期间,特别是在第一波高强度传播期间,COVID-19在中国江苏省既往感染者中的再感染率,并确定与再感染相关的风险因素:流行病学调查于 2023 年 2 月和 3 月通过电话访谈和面对面访问进行。统计分析包括分类数据的卡方检验(Chi-square)或费雪精确检验(Fisher`s exact)、数字数据的学生 t 检验、影响因素的泊松回归(Poisson regression)和累积再感染风险的卡普兰-梅耶(Kaplan-Meier):在接受调查的 12 910 人中,发现了 957 例(7.4%)再感染病例。不同时期的再感染率差异很大:2020 年 1 月至 2 月为 42.5%,2021 年 7 月至 8 月为 15.5%,2022 年 3 月至 4 月为 6.7%,2022 年 9 月至 10 月为 1.1%。女性和 18-50 岁的人更容易再次感染。接种四剂疫苗的人群再感染风险降低,相对风险为0.25(p = 0.019):结论:对于容易再次感染 COVID-19 的人群,尤其是女性和 18-50 岁的年轻人,接种四剂或更多剂量的疫苗可有效降低重复感染的可能性。这些发现强调了在 COVID-19 预防工作中优先接种疫苗和保护高危人群的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
5.30%
发文量
239
审稿时长
4-8 weeks
期刊介绍: The Journal of Infection in Developing Countries (JIDC) is an international journal, intended for the publication of scientific articles from Developing Countries by scientists from Developing Countries. JIDC is an independent, on-line publication with an international editorial board. JIDC is open access with no cost to view or download articles and reasonable cost for publication of research artcles, making JIDC easily availiable to scientists from resource restricted regions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信